Pipettes, blue light, a gloved hand. The category has one stock visual language, and behind it sits the only thing your reader came for: what was measured, in whom, against what, and how sure you are.
Five reasons biotech, medtech and diagnostics websites underperform, even when the engineering behind them is excellent.
What a clinician needs first, what a partner needs, and where the investor lands.
Mechanism of action or device, modelled and animated to explain rather than to impress.
Endpoints, cohorts and trial status designed to be read on a phone with conditions intact.
A system applied page by page, not one template stretched across the site.
Webflow or static, built in-house, tuned for Core Web Vitals on a poor connection.
Structured, fast and quotable, so search engines rank it and answer engines state your stage and evidence correctly.
Weeks from kickoff to live. Fixed scope, fixed timeline, one price.
Stock laboratory photography. If there is a visual on the page, it explains a mechanism.
Disciplines in one room: strategy, copy, design, 3D, build and collateral.
A fast, well-built site cannot rescue unclear positioning. If the category and the moat are not settled, start there.
Yes. Custom 3D is in-house, and mechanism animation is one of the few things that genuinely helps a non-specialist understand a therapeutic.
Yes, and we plan for it. Building the claim boundaries in at the writing stage is far cheaper than discovering them at review.
Either. Webflow when the team needs to edit without us, static when performance and control matter more.
Nine to sixteen weeks for design, 3D and build. Fixed scope, fixed timeline, one price.
Yes, and it is the normal starting point. Most of what makes a deep tech company defensible is unpublished.
Thirty minutes, no deck. We will tell you what your site is hiding, what it is loading badly, and what an answer engine currently thinks you do.
Book a 30-minute audit →(opens in a new tab)